NDC 68382-711

mesalamine 1.2 g tablet, delayed release

On the label: Zydus Pharmaceuticals (USA) Inc..

India: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Zydus Lifesciences LimitedAhmedabad, IndiaMakes it and tests it Problems found, fixed voluntarilyAug 5, 2022 · 10 inspections, 3 with FDA action

Product details

Generic drug
Mesalamine: every company that makes it
Form
tablet, delayed release, oral
Strength
1.2 g
Approval
ANDA ANDA091640
On the market since
Jun 19, 2017
Package NDCs
68382-711-19 68382-711-64
Official label
DailyMed (National Library of Medicine), updated Oct 27, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?